FENNEC PHARMACEUTICALS INC. — Director's Dealing 2024

Apr 23, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2024-04-19

Reporting Person: Haigh Adrian (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-04-19	Common Shares	M	22222	$2.31	Acquired	22222	Direct
2024-04-19	Common Shares	S	22222	$9.335	Disposed	0	Direct
2024-04-22	Common Shares	M	22223	$2.31	Acquired	22223	Direct
2024-04-22	Common Shares	S	22223	$9.316	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-04-19	Option	$2.31	M	22222	Disposed	2024-04-25	Common Shares (22222)	Direct
2024-04-22	Option	$2.31	M	22223	Disposed	2024-04-25	Common Shares (22223)	Direct

Footnotes

F1: Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.

F2: Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.

F3: Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.

F4: Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.

F5: Represents option exercise pursuant to a 10b5-1 plan dated August 17, 2023.

F6: Represents option exercise pursuant to a 10b5-1 plan dated August 17, 2023.